---
title: First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver
  failure
date: '2024-03-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38490194/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240316180700&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Diminished hepatocyte regeneration is a key feature of acute and chronic
  liver diseases and after extended liver resections, resulting in the inability to
  maintain or restore a sufficient functional liver mass. Therapies to restore hepatocyte
  regeneration are lacking, making liver transplantation the only curative option
  for end-stage liver disease. Here, we report on the structure-based development
  and characterization (nuclear magnetic resonance [NMR] spectroscopy) of first-in-class
  ...
disable_comments: true
---
Diminished hepatocyte regeneration is a key feature of acute and chronic liver diseases and after extended liver resections, resulting in the inability to maintain or restore a sufficient functional liver mass. Therapies to restore hepatocyte regeneration are lacking, making liver transplantation the only curative option for end-stage liver disease. Here, we report on the structure-based development and characterization (nuclear magnetic resonance [NMR] spectroscopy) of first-in-class ...